Preclinical and Clinical Antiallergic Effect of Olopatadine 0.2% Solution 24 Hours after Topical Ocular Administration

Author: Vogelson Cullen T.   Abelson Mark B.   Pasquine Terri   Stephens Donna M.   Gamache Daniel A.   Gross Robert D.   Robertson Stella M.   Yanni John M.  

Publisher: OceanSide Publications, Inc

ISSN: 1539-6304

Source: Allergy and Asthma Proceedings, Vol.25, Iss.1, 2004-01, pp. : 69-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content